Abstract
The Pre-analytical phase begins the at the moment the blood supply to the tissue is interrupted in taking the biopsy or resecting the lesion. It ends with the cutting of tissue sections for subsequent examination by morphologic methods, or extraction methods for molecular or genetic methods.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: an update. World J Gastroenterol. 2016;22:4619–25. https://doi.org/10.3748/wjg.v22.i19.4619.
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–68.
Barisoni L, Lafata KJ, Hewitt SM, et al. Digital pathology and computational image analysis in nephropathology. Nat Rev Nephrol. 2020;16:669–85. www.nature.com/nr.neph
Bhargava R, Clark BZ, Carter GJ, Brufsky AM, Dabbs DJ. The healthcare value of the Magee decision algorithm™: use of Magee equations™ and mitosis score to safely forgo molecular testing in breast cancer. Mod Pathol. 2020;33(8):1563–70. https://doi.org/10.1038/s41379-020-0521-4.
Cheung CC, D’Arrigo C, Dietel M, Francis GD, Fulton R, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Taylor CR, Vyberg M, Zhou X, Torlakovic EE. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine—part 4: tissue tools for quality assurance in immunohistochemistry. From the international society for immunohistochemistry and molecular morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017;25:227–30.
Dodson A, Parry S, Lissenberg-Witte B, Haragan A, Allen D, O’Grady A, McClean E, Hughes J, Miller K, Thunissen E. External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different. J Pathol. 2019. https://doi.org/10.1002/cjp2.153.
Hewitt SM, Robinowitz M, Bogen SA, Gown AM, Kalra KL, Otis CN, Spaulding B, Taylor CR. Quality assurance for design control and implementation of immunohistochemistry assays: approved guidelines, vol. 31. 2nd ed. Wayne. PA: Clinical Lab Standards Institute; 2011. p. 4.
Kinney MC, Higgins RA, Am M. Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med. 2011;135:19–43.
Lu S, Stein JE, Rimm DL, Wang DW, Bell JM, Johnson DB, Sosman JA, Schalper DA, Anders RA, Wang H, Hoyt C, Pardoll DM, Danilova L, Taube JM. Comparison of biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade a systematic review and meta-analysis. Jama Oncol. 2019. https://doi.org/10.1001/jamaoncol.2019.1549.
NordiQC. Assessment run C5 2019. PD-L1 (lung). 2019. https://www.nordiqc.org/downloads/assessments/121_102.pdf
Phillips T, Simmons P, Inzunza HD, Cogswell J, Novotny J, Taylor CR, Zhang X. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non small cell lung cancer. Appl Immunohistochem Mol Morph. 2015;23:541–9. https://doi.org/10.1097/PAI.0000000000000256.
Phillips T, Millett MM, Zhang X, Jansson M, Cleveland R, Simmons P, Cherryholmes G, Carnahan J, William J, Spaulding B, Satnick IR, Inzuna HD, Taylor CR, Cogswell J, Novotny J, Oroudjev E, Winther H. Development of a diagnostic programmed cell death 1-ligand 1 immunohistochemistry assay for nivolumab therapy in melanoma. Appl Immunohistochem Mol Morph. 2018;26:6–12.
Rinnerthaler G, Gampenrieder SP, Greil R. HER2 directed antibody-drug-conjugates beyond T-DM1 in breast cancer. Int J Mol Sci. 2019;20:1115. https://doi.org/10.3390/ijms20051115.
Sheppard E, Madej RM, Alfaro MP, et al. Collection, transport, preparation, and storage of specimens for molecular methods. 2nd ed. Wayne, PA: Clinical Lab Standards Institute; 2020. MM13
Skidmore L, Sakamuri S, Knudsen KA, Hewet AG, Milutinovic S, Barkho W, Biroc SL, Kirtley J, Marsden R, Storey K, Lopez I, Yu W, Fang S-Y, Yao S, Gu Y, Tian F. ARX788, a site-specific anti-HER2 antibody–drug conjugate, demonstrates potent and selective activity in HER2-low and T-DM1–resistant breast and gastric cancers. Mol Cancer Ther. 2020;19:1833–43. https://doi.org/10.1158/1535-7163.MCT-19-1004. https://mct.aacrjournals.org/content/19/9/1833
Taylor CR. Paraffin section immunocytochemistry for estrogen receptor: the time has come. Cancer. 1996;77:2419–22.
Taylor CR. Whole slide imaging- issues for use in diagnostic pathology: ‘routine;’ stains, immunohistochemistry and predictive markers. Biotech Histochem. 2014;89:419–23. https://doi.org/10.3109/10520295.2013.861512.
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu E, Swanson P, Taylor CR, Vyberg M. Standardization of positive controls and introduction of immunohistochemistry critical assay performance controls (iCAPCs) in diagnostic immunohistochemistry: recommendations from the international ad hoc committee. Appl Immunohistochem Mol Morph. 2015;23:1–18.
Verma S, Kumar M, Kumari M, Mehrotra R, RAS K, Goel M, Kumar A, Kant S. An immunohistochemical study of anaplastic lymphoma kinase and epidermal growth factor receptor mutation in non-small cell lung carcinoma. J Clin Diagn Res. 2017;11:EC22–5. https://doi.org/10.7860/JCDR/2017/27941.10279.
Yaziji H, Taylor CR. PD-L1 assessment for targeted therapy testing in cancer: urgent need for realistic economic and practice expectations. Appl Immunohistochem Mol Morph. 2017;25:1–3.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jasani, B., Huss, R., Taylor, C.R. (2021). Pre-Analytic Phase: Test Selection; Specimen Acquisition and Handling. In: Precision Cancer Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-84087-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-84087-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84086-0
Online ISBN: 978-3-030-84087-7
eBook Packages: MedicineMedicine (R0)